Top US Court to Hear Challenge to Purdue Pharma's $6 Billion Opioid Settlement
- The Supreme Court is hearing oral arguments regarding the approval of a controversial agreement by OxyContin-maker Purdue Pharma, which would provide billions of dollars to victims of the opioid epidemic while protecting the Sackler family from lawsuits.
- The deal involves the Sackler family paying between $5.5 billion to $6 billion to help fight the opioid crisis, with the majority going to states, local governments, and Native American tribes.
- If approved, the settlement would shield the Sackler family from future lawsuits and create a new company, Knoa Pharma, to distribute opioid addiction treatments and overdose reversal medicines.
Insights by Ground AI
Does this summary seem wrong?
Coverage Details
Total News Sources0
Leaning Left38Leaning Right22Center76Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 28%
C 56%
R 16%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
